Genes Encoding Fibrinogen and Cardiovascular Risk
- 1 November 2001
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 38 (5) , 1199-1203
Abstract
The role of fibrinogen in cardiovascular disease has been extensively studied, and meta-analyses have definitively confirmed that high levels of fibrinogen are associated with an increased risk of the disease. In recent years, several polymorphisms have been identified in the fibrinogen chain genes that contribute to determine the levels of fibrinogen in the general population. The fibrinogen β-chain gene has been more extensively studied because the β-chain synthesis is the limiting step in the production of mature fibrinogen. Overall, the studies show an association between β-fibrinogen chain polymorphisms and the levels of fibrinogen. In contrast, the majority of the studies did not find any relation with the risk of cardiovascular disease. The individual responses to gender or to environmental stimuli such as smoking, physical exercise, or infections may be genetically determined, and genetic variability underlies changes in biological reactions that contribute to differences in cardiovascular risk. In the future, gene-environment interactions should be considered in evaluating the relevance of genetic variations on the risk of cardiovascular disease.Keywords
This publication has 32 references indexed in Scilit:
- β-Fibrinogen Gene −455G/A Polymorphism and Coronary Heart Disease Incidence The Atherosclerosis Risk in Communities (ARIC) StudyAnnals of Epidemiology, 2001
- The effects of genotype and infant weight on adult plasma levels of fibrinogen, factor VII, and LDL cholesterol are additive.Journal of Medical Genetics, 1997
- A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study.Journal of Clinical Investigation, 1997
- β-fibrinogen gene −455 G/A Polymorphism and Fibrinogen Levels: Risk factors for coronary artery disease in subjects with NIDDMDiabetes Care, 1996
- Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A−455 (HaeIII), C/T−148 (HindIII/AluI), T/G+1689 (AvaII), andBclI (β-fibrinogen) andTaqI (α-fibrinogen), and their detection by PCRHuman Mutation, 1994
- Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart StudyThe Lancet, 1993
- Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Serum cholesterol, triglycerides, and aggression in the general populationThe Lancet, 1992
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984